KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Medpace Holdings (MEDP) over the last 11 years, with Q3 2025 value amounting to $1.3 billion.

  • Medpace Holdings' Total Current Liabilities rose 2329.28% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 2329.28%. This contributed to the annual value of $1.1 billion for FY2024, which is 1939.42% up from last year.
  • Per Medpace Holdings' latest filing, its Total Current Liabilities stood at $1.3 billion for Q3 2025, which was up 2329.28% from $1.2 billion recorded in Q2 2025.
  • In the past 5 years, Medpace Holdings' Total Current Liabilities ranged from a high of $1.3 billion in Q3 2025 and a low of $447.3 million during Q1 2021
  • In the last 5 years, Medpace Holdings' Total Current Liabilities had a median value of $879.0 million in 2022 and averaged $858.3 million.
  • Per our database at Business Quant, Medpace Holdings' Total Current Liabilities surged by 8598.1% in 2022 and then plummeted by 301.74% in 2023.
  • Quarter analysis of 5 years shows Medpace Holdings' Total Current Liabilities stood at $557.2 million in 2021, then surged by 44.19% to $803.5 million in 2022, then increased by 15.14% to $925.1 million in 2023, then rose by 19.39% to $1.1 billion in 2024, then increased by 16.24% to $1.3 billion in 2025.
  • Its last three reported values are $1.3 billion in Q3 2025, $1.2 billion for Q2 2025, and $1.1 billion during Q1 2025.